An uneasy calm has descended on the markets since the end of the first quarter put a stop to the heavy liquidation in bonds and some gained the sense that commodities were perhaps a little overcooked. The rebalancing and retracements those two entailed could yet run further, but we very much doubt that we’ve seen the last of the inflationary wave.
China’s ports are humming, its exports booming to the point that it is causing evident stress in maritime trade. Freight rates are soaring and dockside space is becoming limited, threatening production and raising costs across the board. Despite the macro strength – and the vote of confidence this has received from forex and equity markets – the last few weeks have been testing ones in credit. Once more the nation’s vast superstructure of debt has creaked and groaned – but just about held firm, once more. One of these fine days…
The ink has not even dried on the US ballot papers (!) but the Market already thinks it knows what this will all mean. And then there’s Pfizer’s vaccine announcement – perhaps similarly preliminary in nature – but, hey, the Herd will always take every silver lining it can find. Some of the themes we touched upon at the end of the Summer are still in play: Japan has been attracting money, non-oil commodities are rallying, gold has lost some lustre, bond yields are creeping higher, and Value may just be topping out at last v Growth.
On the eve of what is shaping up to be a particularly momentous US election, we offer our view of what is at stake – both in the markets and out in the real world, far beyond the flickering screens of the trading room.
Though the latest set of profit data for China’s industrial concerns were outwardly positive, there are still many unresolved questions hanging over both the economy and the country’s politics, some of which we examine here. None of that is likely to deter bond investors and ETF buyers, of course, since their principal concern will be to bring their holdings into line with a major benchmark index which has just created a vast source of funds for Xi Jinping’s minions to exploit. We ask: should they?
OPEN ACCESS FOR A LIMITED TIME ONLY.
It’s not just the leaves that often turn when the year begins, with gathering pace, to slip towards its chilly end. Markets often do, too.
Given this backdrop, the sell-off in the Nasdaq – in the marvelled-at ‘Growth’ stocks, in the FAANGs, and in Tesla – comes at a moment which is particularly intriguing for reasons which go far beyond whatever coup SoftBank may or may not have attempted and whether those irritating Lockdown Livermores have finally gotten their comeuppance.
As is by now widely reported, China stocks have been on something of a tear in the past few weeks, with the CSI300, for example, up by around 20% in that time. The usual suspects have been at work as the PBOC has encouraged a renewed money flood into being and those desperate for an income – and possibly with little else to do, at present – are enticed back into what is merely the latest in the nation’s rolling series of mania and speculative booms.